The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
40
No.
27
July 04, 2014
- Harvard Physician Whose Cancer Was Spread Through Morcellation Seeks to Revamp FDA Regulation of Medical Devices
- Challoner: We Recommended FDA Replace 510(k) Clearance
- Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial
- BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions
- In Brief: Ma and Tyner Receive Award From AAAS
TCL
Vol.
40
No.
28
July 11, 2014
- NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants
- After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant
- Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer
- AACR Changes Its Logo— For The Fifth Time Since 2000
- NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available
- In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology
- Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL
TCL
Vol.
40
No.
Jul 15 special report
July 15, 2014
TCL
Vol.
40
No.
29
July 18, 2014
- DePinho’s Handling Of MD Anderson Tenure Dispute Triggers Formal Investigation by AAUP
- Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson In U.S. News & World Report Ranking
- Capitol Hill: Advocates Lobby Congress To Close Medicare Loophole For Colonoscopy Coverage
- In Brief: Jennifer Pietenpol Named to IOM Cancer Policy Board
TCL
Vol.
40
No.
30
July 25, 2014
- FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators
- GYN Group: Open Surgery Would Cost More Lives Than Morcellation
- Capitol Hill: Sen. Harkin Introduces NIH Funding Bill That Boosts Budget to $46.2 Billion by 2021
- Appropriations: Senate Committee Approves 4.5 Percent Cut To Defense Dept. Cancer Research Funding
- In Brief: Jordan To Join MD Anderson Cancer Center
CCL
Vol.
37
No.
7
July 25, 2014
- Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial
- IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover
- Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks
- Volasertib and LDAC Doubled Response in Older Patients
- Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial
- Study: Negative HPV Test More Accurate than Negative Pap Test In Predicting Cervical Cancer Risk
- Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma
- NCI CTEP-Approved Trials For the Month of July
- Zydelig Tablets Approved For Three Blood Cancers
TCL
Vol.
40
No.
31
August 01, 2014
- J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer
- FDA Moves to Regulate Lab-Developed Tests
- Surgeon General Issues Call To Reduce Skin Cancer Rates
- PCORI Approves $54.8 Million For Clinical Effectiveness Research
- Anonymous $100 Million Gift Moves OHSU Within $82 Million Of Reaching $1 Billion Goal
- Letter to the Editor: Expanding the Horizons Of Proton Beam Therapy
- In Brief: IOM Cancer Policy Forum names six at-large members
- FDA News: Zydelig approved in three B-cell blood cancers
TCL
Vol.
40
No.
32
August 08, 2014
- “Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges
- Conversation with The Cancer Letter: Daniel Hayes Leads Tour of Caris Website
- Caris Officials Respond To Questions Submitted By The Cancer Letter
- NCI Launches NCORP with 53 Grants Totaling $465 Million
- Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95
- In Brief: Peter Pisters named CEO of University Health Network in Toronto